Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2022) 81 EP145 | DOI: 10.1530/endoabs.81.EP145

ECE2022 Eposter Presentations Calcium and Bone (114 abstracts)

Autosomal dominant hypocalcaemia type 1 with intact PTH and relative hypocalciuria.

Razan Ali Rashid 1 , Richard Quinton 1 & Ashwin Joshi 2

1Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Foundation Trust, Department of Endocrinology and Diabetes, Newcastle upon Tyne, UK; 2Sunderland Royal Hospital, South Tyneside and Sunderland NHS Foundation Trust, Department of Endocrinology Diabetes and Metabolic Medicine, Sunderland, UK.

Autosomal Dominant Hypocalcaemia (ADH) type 1 is caused by activating mutations of the calcium-sensing receptor (CaSR) gene. Although a rare condition, the exact prevalence is uncertain as patients are asymptomatic and, historically, were sometimes diagnosed with hypoparathyroidism (HPT) due insensitivity of earlier PTH assays and failure to check urinary calcium. The consequences of an erroneous diagnosis of HPT in patients with ADH can be profound, as treatment with calcium salts or activated vitamin D characteristically result in more severe hypercalciuria and nephrocalcinosis. A 28-year-old female was referred with hypocalcaemia, extreme tiredness and generalised muscle aches that persisted despite correction of hypovitaminosis D. She had no paresthesia symptoms of tetany or muscle spasms, but suffered from intermittent restless legs at night. There was no history of recurrent urinary tract infections or kidney disease. She had a normal childhood with no significant past medical history. There were no significant medical or genetic conditions in the family, except for type II diabetes. She gave birth to a healthy girl 5 years ago with no complications. She had gastric banding for obesity a year ago and recovered well from the surgery with no complications. She is not on regular medications. On examination, she was clinically euthyroid, with positive Chvostek’s but negative Trousseau’s signs. Other systems were unremarkable. Height was 1.69 m. Her kidney ultrasound showed no renal calculi. Genetic analysis of the patient identified a heterozygous autosomal dominant CASR variant: c.2497G>T (p.Val833Phe) diagnosing her with Autosomal Dominant Hypocalcaemia Type 1 (ADH). This gene variant has not been identified in the gnomAD population database yet. In conclusion, hypocalcaemia needs to be investigated as we now have better assays to detect low normal PTH levels. Misdiagnosing ADH type 1 with hypocalcaemia or HPT increases the risk of nephrocalcinosis and hypercalciuria in those patients.

Laboratory analysis (Table 1):
ParameterResultsNormal Range
Corrected calcium level1.92 mmol/l2.20–2.60 mmol/l
Magnesium0.81 mmol/l0.7–1.20 mmol/l
Phosphate1.45 mmol/l 0.80–1.50 mmol/l
Alkaline phosphatase81 u/l30–130 u/l
Potassium5.1 mmol/l3.50–5.30 mmol/l
Creatinine104 umol/l45–85 umol/l
Vitamin D57.6 ng/l
TSH:1.00 mIU/l0.30–4.50 mIU/l
Calcium Fractional Excretion1.38%
Urinary Calcium/Creatinine0.22 mmol/umol
PTH4.1 pmol1.10–6.90 pmol
Tissue transglutaminase antibodyNegative

Volume 81

European Congress of Endocrinology 2022

Milan, Italy
21 May 2022 - 24 May 2022

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.